Cancer Research Cancer Epigenetics  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 5574-5578, November 1, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singhal, R. L.
Right arrow Articles by Weber, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singhal, R. L.
Right arrow Articles by Weber, G.

1-Phosphatidylinositol 4-Phosphate 5-Kinase (EC 2.7.1.68): A Proliferation- and Malignancy-linked Signal Transduction Enzyme1

Radhey L. Singhal, Noemi Prajda2, Y. Albert Yeh and George Weber3

Laboratory for Experimental Oncology, Indiana University School of Medicine, Indianapolis, Indiana 46202-5200

The activity of PIP kinase (1-phosphatidylinositol 4-phosphate 5-kinase; EC 2.7.1.68), the second ATP-utilizing enzyme of 1,4,5-trisphosphate and diacylglycerol biosynthesis, was determined in the rat in a spectrum of transplantable solid hepatomas of different growth rates and in normal tissues of high and low cell renewal rates. In a standard isotopic method developed for the assay, the enzyme activity was linear with time for 4 min and proportional with protein concentration over a range of 0.05 to 1 mg per 0.135-ml reaction mixture. The apparent Km for the substrate PIP (phosphatidylinositol 4-phosphate) and for ATP and Mg2+ in normal liver were 0.06, 0.5, and 4.2 mM, respectively, and in rapidly growing hepatoma 3924A, 0.08, 0.7, and 7.1 mM. The kinase activity in adult Wistar rat liver was 0.046 ± 0.003 nmol/h/mg protein. In hepatomas of slow and intermediate growth rates, PIP kinase activity increased 3.3–9.7-fold, and in hepatoma 3924A, it was elevated 45-fold over that of normal liver. When hepatoma 3924A cells were plated and expressed their proliferative program, enzyme activity increased 4.3-fold in mid-log phase. To further clarify the linkage between PIP kinase activity and proliferation, enzyme activity was determined in rat organs of high and low cell renewal capacity. The PIP kinase activity in rat thymus, bone marrow, spleen, and testes was 5.4-, 6.3-, 4.8- and 4.3-fold higher, respectively, than in normal rat liver; in lung, brain, skeletal muscle, renal cortex, and heart, the activities were low. In all tissues examined, the activity of PIP kinase was 4.6 to 18% of that of phosphatidylinositol kinase.

Since enzymes of crucial significance frequently have short half-lives, the decay rates of PIP kinase were examined in liver, bone marrow, and hepatoma 3924A in rats injected with cycloheximide, which inhibits protein biosynthesis. In cycloheximide-treated animals, PIP kinase had the shortest decay rate (t1/2 = 0.12 h) in comparison with eight enzymes of purine and pyrimidine biosynthesis of rat bone marrow (t1/2 = 0.6 to 4.3 h). In liver and solid hepatoma 3924A, the activity of PIP kinase was degraded less rapidly (t1/2 = 5 h).

The relationship of PIP kinase activity with proliferation and transformation is apparent in the high activity in thymus, bone marrow, spleen, and testes and in the increased activities in the rat hepatomas of different growth rates. The coordinate increases in phosphatidylinositol and PIP kinase activities suggest that the capacity for signal transduction is heightened in cancer cells. The elevated inositol 1,4,5-trisphosphate concentrations observed in the hepatomas support this conclusion. Since both kinase activities are linked with malignancy, these may well be sensitive targets for designing new chemotherapeutic agents.

1 This work was supported, in part, by USPHS Outstanding Investigator Grant CA-42510 (to G. W.) and by OTKA Grant 3024 (to N. P.).

2 Current address: National Institute of Oncology, Rath Gy. utca, Budapest, Hungary.

3 To whom requests for reprints should be addressed, at Laboratory for Experimental Oncology, Indiana University School of Medicine, 702 Barnhill Drive, Indianapolis, IN 46202-5200.

Received 6/27/94. Accepted 8/30/94.




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
I. van den Bout and N. Divecha
PIP5K-driven PtdIns(4,5)P2 synthesis: regulation and cellular functions
J. Cell Sci., November 1, 2009; 122(21): 3837 - 3850.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. J. Ritchie, C. J. Henderson, X. J. Wang, O. Vassieva, D. Carrie, P. B. Farmer, M. Gaskell, K. Park, and C. R. Wolf
Glutathione Transferase {pi} Plays a Critical Role in the Development of Lung Carcinogenesis following Exposure to Tobacco-Related Carcinogens and Urethane
Cancer Res., October 1, 2007; 67(19): 9248 - 9257.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
P. A. Williams, J.-P. Wuarin, P. Dou, D. J. Ferraro, and F. E. Dudek
Reassessment of the Effects of Cycloheximide on Mossy Fiber Sprouting and Epileptogenesis in the Pilocarpine Model of Temporal Lobe Epilepsy
J Neurophysiol, October 1, 2002; 88(4): 2075 - 2087.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Theander, D. P. Lew, and O. Nusse
Granule-specific ATP requirements for Ca2+-induced exocytosis in human neutrophils. Evidence for substantial ATP-independent release
J. Cell Sci., July 15, 2002; 115(14): 2975 - 2983.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Castellino, G. J. Parker, I. V. Boronenkov, R. A. Anderson, and M. V. Chao
A Novel Interaction between the Juxtamembrane Region of the p55 Tumor Necrosis Factor Receptor and Phosphatidylinositol-4-phosphate 5-Kinase
J. Biol. Chem., February 28, 1997; 272(9): 5861 - 5870.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.